| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8739804 | Journal of Clinical Virology | 2018 | 4 Pages |
Abstract
We found no evidence that HPyV seroprevalence is associated with subsequent development of cSCC and observed variable stability of antibodies to polyomaviruses.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Annika Antonsson, Rachel E. Neale, Peter O'Rourke, Leesa Wockner, Angelika Michel, Michael Pawlita, Tim Waterboer, Adèle C. Green,